Not one single announcement produced by the Company has had a positive material effect on the share price. Not one.
Except for the 2 CR. The one last year thumped the share price down to a paltry 1 cent. One year later we get another CR for 0.05 cent.
So, far not one critical milestone has been achieved as set out by the Company at its AGM.
We have no news on GBA Germany approval.
Ann: UK Private Insurer Approves Reimbursement for OncoSil, page-13
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $85.35K | 9.403M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1278254 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 11789637 | 16 |
View Market Depth
| Last trade - 15.17pm 26/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |